CSF Management Market - Global Industry Analysis

Table Of Content

Methodology

Free Analysis

Hydrocephalus is the swelling of brain which is caused as a result of excessive build up of cerebrospinal fluid (CSF). This excessive CSF can severely impact the patient, as it can increase intracranial pressure (ICP) which can lead to herniation, intracranial hematoma or cerebral edema. Hydrocephalus is caused due to multiple reasons such as colloid cyst, craniofacial anomalies, benign intracranial cysts, intracranial hemorrhage, choroid plexus tumor, and meningitis. CSF management plays a vital role in treatment of such number of brain and nervous system related disorders.

Increase in elderly population globally is expected to be the major driver for the global CSF management market. In addition, increasing demand for minimally invasive procedures is expected to trigger the growth of CSF management market in the coming years. Emerging economies such as India, Brazil and China are expected to offer growth opportunities for CSF management market during the forecast period. However, high cost of surgery may pose the challenge to CSF management market.

Based on product, CSF management market has been segmented into CSF drainage systems and CSF shunts.  CSF management market was dominated by CSF shunts segment which accounted for largest share as CSF shunts help brain to return to a normal size by relieving the symptoms of hydrocephalus. Further it is expected to continue its dominance over the forecast period. However, risk associated with CSF shunts such as it leads to infection that is caused due to the patient’s own skin organism may affect the for growth of this segment. A CSF drainage system eliminates blood clots from intrathecal spaces, clears CSF from ventricles, and reduces the incidence of vasospasm. CSF drainage system is comparatively more accurate and cost-effective. The segment is likely to expand at the fastest growth rate during the forecast period.

The CSF management market is segmented into end-user such as hospitals, outpatient facilities, and others. In terms of revenue, the hospitals end-user segment dominated the market in 2015.  At present, hospitals end-user is acting as drivers for the growth of the CSF management market. The increase in demand for 3D cell surgery across the world is creating the demand for CSF management across the globe.

In terms of region, the report segments the global CSF management market into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America is expected to remain the dominant region over the forecast period. Presence of large number of elderly population coupled along with technological advancement in this region is driving the CSF management market in North America. Asia Pacific is projected to be the fastest growing region for the CSF management market during the forecast period. The market growth in countries such as India and China as a result of increasing medical tourism and demand for minimal invasive technologies is expected to boost market in this region.  Europe is expected to experience steady growth in the years to come as a result of growing elderly population in this region.

Some of the key players in B. Braun Melsungen AG, DePuy Synthes, Integra LifeSciences Holding Corporation, Codman EDS, Medtronic plc, Sophysa S.A., Spiegelberg GmbH & Co. KG, BeckerSmith Medical, Inc., and Möller Medical GmbH., among others.